BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

Bot Chart, page-12094

  1. 3,856 Posts.
    lightbulb Created with Sketch. 412
    Technegas is best in class and is expected to displace existing products. It has essentially no competition in it's space. CYC has an 8 year plan and people that were expecting the moon after FDA approval were not well researched.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.